Artificial Intelligence In Drug Repurposing Global Market Report 2025

Description

Artificial intelligence in drug repurposing refers to the use of artificial intelligence techniques to identify new medical applications for existing drugs. It applies advanced data analytics, machine learning, and predictive modeling to examine biological, chemical, and clinical data for potential therapeutic matches. This approach speeds up drug discovery, lowers research costs, and improves the efficiency of pharmaceutical development.

The primary components of artificial intelligence in drug repurposing include software and platforms and services. Software and platforms consist of digital tools and environments that facilitate the development, deployment, and utilization of applications and services. It employs various technologies such as machine learning or deep learning, natural language processing, knowledge graphs and network-based artificial intelligence, generative artificial intelligence and large language models, and computer vision. The different deployment modes include cloud-based and on-premises. Various therapeutic areas include oncology, neurology, cardiovascular diseases, infectious diseases, immunology, metabolic disorders, and rare diseases, and they serve several end-users, including pharmaceutical and biotechnology companies, contract research organizations, academic and research institutes, healthcare providers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are significantly impacting the information technology sector, particularly in hardware manufacturing, data infrastructure, and software deployment. Higher duties on imported semiconductors, circuit boards, and networking equipment have raised production and operational costs for tech firms, cloud service providers, and data centers. Companies relying on globally sourced components for laptops, servers, and consumer electronics are facing longer lead times and increased pricing pressures. In parallel, tariffs on specialized software tools and retaliatory measures from key international markets have disrupted global IT supply chains and reduced overseas demand for U.S.-developed technologies. To navigate these challenges, the sector is accelerating investments in domestic chip fabrication, diversifying supplier bases, and adopting AI-driven automation to enhance operational resilience and cost efficiency.

The artificial intelligence in drug repurposing market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in drug repurposing market statistics, including artificial intelligence in drug repurposing industry global market size, regional shares, competitors with a artificial intelligence in drug repurposing market share, detailed artificial intelligence in drug repurposing market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in drug repurposing industry. This artificial intelligence in drug repurposing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence in drug repurposing market size has grown exponentially in recent years. It will grow from $0.87 billion in 2024 to $1.05 billion in 2025 at a compound annual growth rate (CAGR) of 20.5%. The growth during the historic period can be attributed to the increasing prevalence of chronic and rare diseases, the rising research and development expenditure, the growing regulatory support, the rising healthcare costs, and the increasing collaborations between pharmaceutical companies and artificial intelligence firms.

The artificial intelligence in drug repurposing market size is expected to see exponential growth in the next few years. It will grow to $2.19 billion in 2029 at a compound annual growth rate (CAGR) of 20.2%. The growth during the forecast period can be attributed to the growing demand for cost-effective drug development, the increasing use of artificial intelligence-powered predictive analytics, the rising prevalence of complex diseases, the growing adoption of cloud infrastructure, and the increasing repurposing opportunities for existing approved drugs. Key trends in the forecast period include innovations in machine learning and generative artificial intelligence applications, developments in predictive modeling and data analytics, technological advancements in large language models for hypothesis generation, innovations in cloud-based artificial intelligence drug discovery platforms, and technological enhancements in multi-omics data integration systems.

The increasing demand for precision medicine is expected to drive the growth of the artificial intelligence in drug repurposing market in the coming years. Precision medicine is a healthcare approach that customizes disease prevention and treatment based on an individual's unique genes, behaviors, and environment. The growing preference for personalized treatments is fueling the expansion of precision medicine, as patients and healthcare providers increasingly seek therapies tailored to individual genetic and lifestyle profiles for improved effectiveness and fewer side effects. Artificial intelligence-driven drug repurposing supports precision medicine by identifying existing drugs that match an individual's genetic or molecular characteristics, enabling more accurate and personalized treatment solutions. For example, in February 2024, according to the Personalized Medicine Coalition, a United States-based nonprofit organization, the Food and Drug Administration approved sixteen personalized therapies targeting rare diseases in 2023, a significant increase compared to six approvals in 2022. Therefore, the rising demand for precision medicine is propelling the growth of the artificial intelligence in drug repurposing market.

Key companies operating in the artificial intelligence in drug repurposing market are concentrating on integrating advanced technologies in drug repositioning, such as computational drug repositioning systems, which systematically identify new therapeutic indications for existing drugs using data-driven analysis of literature and biological information. A computational drug repositioning system refers to a technology-based platform that employs artificial intelligence, machine learning, and data mining to systematically analyze existing drugs, compounds, and biological data. For instance, in November 2023, Tempus, a United States-based provider of artificial intelligence-based precision medicine solutions, announced a multi-year strategic collaboration with Recursion, a United States-based clinical-stage biotechnology company, valued at up to one hundred sixty million dollars over five years. The collaboration grants Recursion access to Tempus' extensive library of de-identified, multimodal oncology data to support biomarker-driven therapeutic development. By leveraging Tempus' large-scale patient datasets alongside Recursion's artificial intelligence-enabled discovery capabilities, the partnership strengthens oncology drug repurposing initiatives, demonstrating how advanced computational platforms combined with real-world clinical data can accelerate the identification of new treatment opportunities.

In January 2024, Cosmos Health Incorporated, a United States-based diversified healthcare company, acquired Cloudscreen for an undisclosed amount. Through this acquisition, Cosmos Health aims to strengthen drug repurposing capabilities and speed up the identification of new therapeutic applications for existing drugs. Cloudscreen is a United States-based company specializing in artificial intelligence-powered drug repurposing solutions.

Major players in the artificial intelligence in drug repurposing market are IBM Corporation, Evogene Ltd., Ginkgo Bioworks Holdings Inc., BioAge Labs Inc., Insilico Medicine Inc., BostonGene Corporation, ISOMORPHIC LABS, Recursion Pharmaceuticals Inc., Deep Genomics Inc., Healx Ltd., Owkin Inc., BullFrog AI Holdings Inc., Aicura Medical GmbH, Kantify, Ignota Labs Ltd., OrphAI Therapeutics, Nabla Bio, Atomwise Inc., BioXcel Therapeutics Inc., and Graph AI.

North America was the largest region in the artificial intelligence in drug repurposing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence in drug repurposing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence in drug repurposing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence in drug repurposing market includes revenues earned by entities by providing services such as predictive modelling, target identification, drug-disease interaction analysis, virtual screening, and clinical data mining. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Drug Repurposing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in drug repurposing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in drug repurposing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence in drug repurposing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Component: Software And Platforms; Services
2) By Technology: Machine Learning Or Deep Learning; Natural Language Processing (NLP); Knowledge Graphs And Network-Based Artificial Intelligence; Generative Artificial Intelligence And Large Language Models (LLMs); Computer Vision
3) By Deployment: Cloud-Based; On-Premises
4) By Therapeutic: Oncology; Neurology; Cardiovascular Diseases; Infectious Diseases; Immunology; Metabolic Disorders; Rare Diseases
5) By End-User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations (CROs); Academic And Research Institutes; Healthcare Providers; Other End-Users
Subsegments:
1) By Software And Platforms: Predictive Analytics Tools; Machine Learning Frameworks; Data Integration Systems; Drug Discovery Platforms; Clinical Trial Simulation Tools
2) By Services: Consulting Services; Data Management Services; Model Training And Optimization Services; Implementation And Integration Services; Support And Maintenance Services
Companies Mentioned: IBM Corporation; Evogene Ltd.; Ginkgo Bioworks Holdings Inc.; BioAge Labs Inc.; Insilico Medicine Inc.; BostonGene Corporation; ISOMORPHIC LABS; Recursion Pharmaceuticals Inc.; Deep Genomics Inc.; Healx Ltd.; Owkin Inc.; BullFrog AI Holdings Inc.; Aicura Medical GmbH; Kantify; Ignota Labs Ltd.; OrphAI Therapeutics; Nabla Bio; Atomwise Inc.; BioXcel Therapeutics Inc.; Graph AI.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r39458

1. Executive Summary

2. Artificial Intelligence In Drug Repurposing Market Characteristics

3. Artificial Intelligence In Drug Repurposing Market Trends And Strategies

4. Artificial Intelligence In Drug Repurposing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence In Drug Repurposing Growth Analysis And Strategic Analysis Framework

5.1. Global Artificial Intelligence In Drug Repurposing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Artificial Intelligence In Drug Repurposing Market Growth Rate Analysis
5.4. Global Artificial Intelligence In Drug Repurposing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Artificial Intelligence In Drug Repurposing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Artificial Intelligence In Drug Repurposing Total Addressable Market (TAM)

6. Artificial Intelligence In Drug Repurposing Market Segmentation

6.1. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Software And Platforms
Services
6.2. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Machine Learning Or Deep Learning
Natural Language Processing (NLP)
Knowledge Graphs And Network-Based Artificial Intelligence
Generative Artificial Intelligence And Large Language Models (LLMs)
Computer Vision
6.3. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cloud-Based
On-Premises
6.4. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Neurology
Cardiovascular Diseases
Infectious Diseases
Immunology
Metabolic Disorders
Rare Diseases
6.5. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Contract Research Organizations (CROs)
Academic And Research Institutes
Healthcare Providers
Other End-Users
6.6. Global Artificial Intelligence In Drug Repurposing Market, Sub-Segmentation Of Software And Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Predictive Analytics Tools
Machine Learning Frameworks
Data Integration Systems
Drug Discovery Platforms
Clinical Trial Simulation Tools
6.7. Global Artificial Intelligence In Drug Repurposing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consulting Services
Data Management Services
Model Training And Optimization Services
Implementation And Integration Services
Support And Maintenance Services

7. Artificial Intelligence In Drug Repurposing Market Regional And Country Analysis

7.1. Global Artificial Intelligence In Drug Repurposing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Artificial Intelligence In Drug Repurposing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence In Drug Repurposing Market

8.1. Asia-Pacific Artificial Intelligence In Drug Repurposing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence In Drug Repurposing Market

9.1. China Artificial Intelligence In Drug Repurposing Market Overview
9.2. China Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence In Drug Repurposing Market

10.1. India Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence In Drug Repurposing Market

11.1. Japan Artificial Intelligence In Drug Repurposing Market Overview
11.2. Japan Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence In Drug Repurposing Market

12.1. Australia Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence In Drug Repurposing Market

13.1. Indonesia Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence In Drug Repurposing Market

14.1. South Korea Artificial Intelligence In Drug Repurposing Market Overview
14.2. South Korea Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence In Drug Repurposing Market

15.1. Western Europe Artificial Intelligence In Drug Repurposing Market Overview
15.2. Western Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence In Drug Repurposing Market

16.1. UK Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence In Drug Repurposing Market

17.1. Germany Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence In Drug Repurposing Market

18.1. France Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence In Drug Repurposing Market

19.1. Italy Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence In Drug Repurposing Market

20.1. Spain Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence In Drug Repurposing Market

21.1. Eastern Europe Artificial Intelligence In Drug Repurposing Market Overview
21.2. Eastern Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence In Drug Repurposing Market

22.1. Russia Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence In Drug Repurposing Market

23.1. North America Artificial Intelligence In Drug Repurposing Market Overview
23.2. North America Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence In Drug Repurposing Market

24.1. USA Artificial Intelligence In Drug Repurposing Market Overview
24.2. USA Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence In Drug Repurposing Market

25.1. Canada Artificial Intelligence In Drug Repurposing Market Overview
25.2. Canada Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence In Drug Repurposing Market

26.1. South America Artificial Intelligence In Drug Repurposing Market Overview
26.2. South America Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence In Drug Repurposing Market

27.1. Brazil Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence In Drug Repurposing Market

28.1. Middle East Artificial Intelligence In Drug Repurposing Market Overview
28.2. Middle East Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence In Drug Repurposing Market

29.1. Africa Artificial Intelligence In Drug Repurposing Market Overview
29.2. Africa Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence In Drug Repurposing Market Competitive Landscape And Company Profiles

30.1. Artificial Intelligence In Drug Repurposing Market Competitive Landscape
30.2. Artificial Intelligence In Drug Repurposing Market Company Profiles
- 30.2.1. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Evogene Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Ginkgo Bioworks Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. BioAge Labs Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Insilico Medicine Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence In Drug Repurposing Market Other Major And Innovative Companies

31.1. BostonGene Corporation
31.2. ISOMORPHIC LABS
31.3. Recursion Pharmaceuticals Inc.
31.4. Deep Genomics Inc.
31.5. Healx Ltd.
31.6. Owkin Inc.
31.7. BullFrog AI Holdings Inc.
31.8. Aicura Medical GmbH
31.9. Kantify
31.10. Ignota Labs Ltd.
31.11. OrphAI Therapeutics
31.12. Nabla Bio
31.13. Atomwise Inc.
31.14. BioXcel Therapeutics Inc.
31.15. Graph AI

32. Global Artificial Intelligence In Drug Repurposing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence In Drug Repurposing Market

34. Recent Developments In The Artificial Intelligence In Drug Repurposing Market

35. Artificial Intelligence In Drug Repurposing Market High Potential Countries, Segments and Strategies

35.1 Artificial Intelligence In Drug Repurposing Market In 2029 - Countries Offering Most New Opportunities
35.2 Artificial Intelligence In Drug Repurposing Market In 2029 - Segments Offering Most New Opportunities
35.3 Artificial Intelligence In Drug Repurposing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer